UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma

European journal of haematology, 2015-06, Vol.94 (6), p.532-539

2015

Volltextzugriff (PDF)

Benign Bone Conditions That May Be FDG-avid and Mimic Malignancy

Seminars in nuclear medicine, 2017-07, Vol.47 (4), p.322-351

2017

Volltextzugriff (PDF)

Prognostic value of tumor necrosis at CT in diffuse large B-cell lymphoma

European journal of radiology, 2015-03, Vol.84 (3), p.372-377

2015

Volltextzugriff (PDF)

Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance

European journal of haematology, 2015-07, Vol.95 (1), p.83-89

2015

Volltextzugriff (PDF)

Malignancy rate of biopsied suspicious bone lesions identified on FDG PET/CT

European journal of nuclear medicine and molecular imaging, 2016-07, Vol.43 (7), p.1231-1238

2016

Volltextzugriff (PDF)

Tumor necrosis at FDG-PET is an independent predictor of outcome in diffuse large B-cell lymphoma

European journal of radiology, 2016-01, Vol.85 (1), p.304-309

2016

Volltextzugriff (PDF)

Radiation-Induced Giant Cell Granuloma Mimicking Relapsed Hodgkin Lymphoma at FDG-PET/CT

Nuclear Medicine and Molecular Imaging , 2017, 51(4), , pp.371-373

2017

Volltextzugriff (PDF)

Current Pathologic Scoring Systems for Metal-on-metal THA Revisions are not Reproducible

Clinical orthopaedics and related research, 2017-12, Vol.475 (12), p.3005-3011

2017

Volltextzugriff (PDF)

Interpretation of Immunohistochemistry for Mismatch Repair Proteins is Only Reliable in a Specialized Setting

The American journal of surgical pathology, 2008-08, Vol.32 (8), p.1246-1251

2008

Volltextzugriff (PDF)

Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?

Nuclear medicine communications, 2016-01, Vol.37 (1), p.23-29

2016

Volltextzugriff (PDF)

Bone marrow biopsy in diffuse large B-cell lymphoma: Useful or redundant test?

Acta oncologica, 2015-01, Vol.54 (1), p.67-72

2015

Volltextzugriff (PDF)

Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?

Acta radiologica (1987), 2015-10, Vol.56 (10), p.1230-1235

2015

Volltextzugriff (PDF)

Where Does Diffuse Large B-Cell Lymphoma Relapse?

Journal of computer assisted tomography, 2016-07, Vol.40 (4), p.531-536

2016

Volltextzugriff (PDF)

Lymphoma grading with FDG-PET/CT readdressed: Direct and timely histopathological correlation study

Acta oncologica, 2016-01, Vol.55 (3), p.386-390

2016

Volltextzugriff (PDF)

Brain glucose metabolism in diffuse large B-cell lymphoma patients as assessed with FDG-PET: impact on outcome and chemotherapy effects

Acta radiologica (1987), 2016-06, Vol.57 (6), p.733-741

2016

Volltextzugriff (PDF)

Prognostic Value of Anemia and C-Reactive Protein Levels in Diffuse Large B-Cell Lymphoma

Clinical lymphoma, myeloma and leukemia, 2015-11, Vol.15 (11), p.671-679

2015

Volltextzugriff (PDF)

Paget's disease of the bone mimicking lymphomatous bone marrow involvement at FDG‐PET

American journal of hematology, 2015-03, Vol.90 (3), p.269-270

2015

Volltextzugriff (PDF)

False‐negative FDG‐PET in histologically proven extensive large cell bone marrow involvement in diffuse large B‐cell lymphoma

American journal of hematology, 2015-07, Vol.90 (7), p.681-681

2015

Volltextzugriff (PDF)

Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study

Skeletal radiology, 2014-09, Vol.43 (9), p.1231-1236

2014

Volltextzugriff (PDF)

Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET-Based Complete Response After First-Line R-CHOP Therapy: Does It Have Any Prognostic Value?

Journal of computer assisted tomography, 2015-09, Vol.39 (5), p.810-815

2015

Volltextzugriff (PDF)

CT-based versus FDG-PET/CT-based NCCN international prognostic index risk stratification in DLBCL

Journal of the National Comprehensive Cancer Network, 2015-02, Vol.13 (2), p.171

2015

Volltextzugriff (PDF)

Bone marrow 18F‐fluoro‐2‐deoxy‐d‐glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B‐cell lymphoma

American journal of hematology, 2014-07, Vol.89 (7), p.726-731

2014

Volltextzugriff (PDF)

Effect of blind bone marrow biopsy on FDG-PET/CT interpretation of the posterior iliac crest in diffuse large B-cell lymphoma

Hematological oncology, 2016-03, Vol.34 (1), p.52-54

2016

Volltextzugriff (PDF)

Does the presence of tumor-induced cortical bone destruction at CT have any prognostic value in newly diagnosed diffuse large B-cell lymphoma?

Skeletal radiology, 2015-05, Vol.44 (5), p.687-694

2015

Volltextzugriff (PDF)

Bone marrow 18 F‐fluoro‐2‐deoxy‐ d ‐glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B‐cell lymphoma

American journal of hematology, 2014-07, Vol.89 (7), p.726-731

2014

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(38)
Humans
(32)
Male
(27)
Aged
(24)
Female
(23)
Middle Aged
(23)
Adult
(19)
Aged, 80 And Over
(17)
Fluorodeoxyglucose F18
(15)
Radiology, Nuclear Medicine & Medical Imaging
(14)
Retrospective Studies
(14)
Positron-Emission Tomography
(11)
Prognosis
(11)
Radiopharmaceuticals
(10)
Diffuse Large B-Cell Lymphoma
(9)
Lymphoma, Large B-Cell, Diffuse - Diagnostic Imaging
(9)
Oncology
(9)
Physics
(9)
Hematology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma

Benign Bone Conditions That May Be FDG-avid and Mimic Malignancy

Prognostic value of tumor necrosis at CT in diffuse large B-cell lymphoma

Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance

Malignancy rate of biopsied suspicious bone lesions identified on FDG PET/CT

Tumor necrosis at FDG-PET is an independent predictor of outcome in diffuse large B-cell lymphoma

Radiation-Induced Giant Cell Granuloma Mimicking Relapsed Hodgkin Lymphoma at FDG-PET/CT

Current Pathologic Scoring Systems for Metal-on-metal THA Revisions are not Reproducible

Interpretation of Immunohistochemistry for Mismatch Repair Proteins is Only Reliable in a Specialized Setting

Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?

Bone marrow biopsy in diffuse large B-cell lymphoma: Useful or redundant test?

Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?

Where Does Diffuse Large B-Cell Lymphoma Relapse?

Lymphoma grading with FDG-PET/CT readdressed: Direct and timely histopathological correlation study

Brain glucose metabolism in diffuse large B-cell lymphoma patients as assessed with FDG-PET: impact on outcome and chemotherapy effects

Prognostic Value of Anemia and C-Reactive Protein Levels in Diffuse Large B-Cell Lymphoma

Paget's disease of the bone mimicking lymphomatous bone marrow involvement at FDG‐PET

False‐negative FDG‐PET in histologically proven extensive large cell bone marrow involvement in diffuse large B‐cell lymphoma

Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study

Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET-Based Complete Response After First-Line R-CHOP Therapy: Does It Have Any Prognostic Value?

CT-based versus FDG-PET/CT-based NCCN international prognostic index risk stratification in DLBCL

Bone marrow 18F‐fluoro‐2‐deoxy‐d‐glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B‐cell lymphoma

Effect of blind bone marrow biopsy on FDG-PET/CT interpretation of the posterior iliac crest in diffuse large B-cell lymphoma

Does the presence of tumor-induced cortical bone destruction at CT have any prognostic value in newly diagnosed diffuse large B-cell lymphoma?

Bone marrow 18 F‐fluoro‐2‐deoxy‐ d ‐glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B‐cell lymphoma

Suchergebnisse filtern